New research comparing HIV medications set to change international recommendations
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Learn MoreApril 7, 2020
Here’s what we know about COVID-19 & HIV
Many questions remain about COVID-19 and what it means for people living with HIV. We explore the research so far
Learn More
Could Cannabis Help Prevent HIV-Related Illnesses?
Drs. Cecilia Costiniuk and Ali Jenabian During the height of the AIDS epidemic in the...
Learn More
CTN 281: Canadian Children Falling Short of UNAIDS target
Quick Take In a new publication from the EPIC4 Study (CTN 281), 73% of Canadian...
Learn More
Interpreting new international study results for the Canadian context
CTN National Director Dr. Aslam Anis was quoted in a Global News story about new findings...
Learn More
So what about the gut?
The advent of combination antiretroviral therapy (cART) has greatly changed the way people live with...
Learn More
Study demonstrates the acceptability of HIV point-of-care testing in inner-city emergency department
A collaborative group of scientists in Vancouver have published results from a study showing the...
Learn More